The impact of computed tomography on pretherapeutic staging in patients with laryngeal cancer: Demonstration of the will Rogers' phenomenon

Head and Neck

Volumn 26, Issue 11, 2004, Pages 972-976

  Champion, Gretchen A ^a   Piccirillo, Jay F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Laryngeal cancer; Stage migration; Staging; Technology assessment

Indexed keywords

ADULT; AGED; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICAL EXAMINATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 8444237517     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20071     Document Type: Review

References (19)

1. Bloom C, Just N, Remy H, Black M, Rossignol M. Laryngeal cancer: is computed tomography a valuable imaging technique? A retrospective analysis. Journal de l'Association canadienne des radiologists (Canadian Association of Radiologists) 1998;49:370-377.
2. Thabet HM, Sessions D, Gado M, Gnepp DA, Harvey J, Talaat M. Comparison of clinical evaluation and computed tomographic diagnostic accuracy for tumors of the larynx and hypopharynx. Laryngoscope 1996;106:589-594.
3. Sulfaro S, Barzan L, Querin F, et al. T staging of the laryngohypopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1989;115:613-620.
4. Hillsamer PJ, Schuller DE, McGhee RB Jr, Chakeres D, Young DC. Improving diagnostic accuracy of cervical metastases with computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 1990; 116:1297-1301.
5. Friedman M, Shelton VK, Mafee M, Bellity P, Grybauskas V, Skolnik E. Metastatic neck disease. Arch Otolaryngol 1984;110:443-447.
6. Stern W, Silver CE, Zeifer BA, Persky MS, Heller KS. Computed tomography of the clinically negative neck. Head Neck 1990;12:109-113.
7. Katsantonis GP, Archer CR, Rosenblum BN, Yeager VL, Friedman WH. The degree to which accuracy of preoperative staging of laryngeal carcinoma has been enhanced by computed tomography. Otolaryngol Head Neck Surg 1986; 95:52-62.
8. Dillon WP. Harnsberger HR. The impact of radiologic imaging on staging of cancer of the head and neck. Semin Oncol 1991;18:64-79.
9. Brehn RB, Pasic TR, Harari PM, Brown WD, Ford CN. Influence of computed tomography on pretherapeutic tumor staging in head and neck cancer patients. Otolaryngol Head Neck Surg 1998;119:628-633.
10. Feinstein AR, Sosin DA, Wells CK. The Will Rogers phenomenon: improved technologic diagnosis and stage migration as a source of nontherapeutic improvement in cancer prognosis. Trans Assoc Am Phys 1984;97:19-24.
11. Pfister DG, Wells CK, Chan CK, Feinstein AR. Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy. Cancer Res 1990;50:4664-4669.
12. Feinstein AR, Pritchett JA, Schimpff CR. The epidemiology of cancer therapy. II. The clinical course: data, decisions, and temporal demarcations. Arch Intern Med 1969; 123:323-344.
13. Feinstein AR, Pritchett JA, Schimpff CR. The epidemiology of cancer therapy. III. The management of imperfect data. Arch Intern Med 1969;123:448-461.
14. Feinstein AR, Pritchett JA, Schimpff CR. The epidemiology of cancer therapy. IV. The extraction of data from medical records. Arch Intern Med 1969;123:571-590.
15. American Joint Committee on Cancer. AJCC cancer staging manual. Philadelphia: Lippincott-Raven; 1997.
16. Stevens MH, Harnsberger HR, Mancuso AA, Davis RK, Johnson LP, Parkin JL. Computed tomography of cervical lymph nodes. Staging and management of head and neck cancer. Arch Otolaryngol 1985;111:735-739.
17. Friedlander PL. The use of genetic markers in the clinical care of patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2003;129:363-366.
18. Bradford CR. Genetic markers of head and neck cancer: identifying new molecular targets. Arch Otolaryngol Head Neck Surg 2003;129:366-367.
19. Koch W. Genetic markers in the clinical care of head and neck cancer: slow in coming. Arch Otolaryngol Head Neck Surg 2003;129:367-368.